| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9685 |
| Human Intestinal Absorption | HIA+ | 0.9952 |
| Caco-2 Permeability | Caco2+ | 0.7824 |
| P-glycoprotein Substrate | Non-substrate | 0.8398 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9285 |
| Non-inhibitor | 0.9472 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7765 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4917 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8589 |
| CYP450 2D6 Substrate | Non-substrate | 0.8767 |
| CYP450 3A4 Substrate | Non-substrate | 0.7542 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7621 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.7661 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7642 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7219 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6419 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6883 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9451 |
| Non-inhibitor | 0.9336 |
| AMES Toxicity | AMES toxic | 0.9447 |
| Carcinogens | Carcinogens | 0.7764 |
| Fish Toxicity | High FHMT | 0.9436 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9929 |
| Honey Bee Toxicity | Low HBT | 0.7367 |
| Biodegradation | Not ready biodegradable | 0.9784 |
| Acute Oral Toxicity | III | 0.6819 |
| Carcinogenicity (Three-class) | Warning | 0.4251 |